{"id":519909,"date":"2010-04-07T13:52:48","date_gmt":"2010-04-07T17:52:48","guid":{"rendered":"http:\/\/blogs.wsj.com\/health\/2010\/04\/07\/so-how-worried-are-public-health-officials-about-xmrv-2\/"},"modified":"2010-04-07T13:52:48","modified_gmt":"2010-04-07T17:52:48","slug":"so-how-worried-are-public-health-officials-about-xmrv","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/519909","title":{"rendered":"So How Worried Are Public-Health Officials About XMRV?"},"content":{"rendered":"

A WSJ article<\/a> Monday reported that a federally funded working group is trying to determine whether a virus known as XMRV poses a risk to the nation\u0092s blood supply. So how worried are public-health experts about XMRV?<\/p>\n

\"chart\"In August, the last time emerging threats were assessed and ranked by the AABB, XMRV hadn\u0092t yet appeared on the group\u0092s radar. (The AABB is an association that includes facilities that collect virtually all of the U.S. blood supply.) But Susan L. Stramer, executive scientific officer at the American Red Cross and a member of the AABB committee that ranked diseases, said that if she had to do so today, she would likely rank XMRV as a \u0093yellow\u0094 agent.<\/p>\n

The committee prioritized the agents \u0097 including dengue and Creutzfeldt-Jakob disease — based on the potential threat to blood safety, the scientific and epidemiologic data available so far and the level of public and regulatory concern. Agents with the highest priority were listed as red, followed by orange, then yellow.<\/p>\n

There isn\u0092t conclusive evidence yet about whether XMRV is transmitted in transfusions or causes disease in people who get transfused blood, but public and regulatory concern exists about XMRV, Dr. Stramer explained. As more information emerges about XMRV, she said, \u0093the classification could change.\u0094<\/p>\n

The AABB published a fact sheet<\/a> about the virus XMRV in January that provides background information about the virus, which has been linked to prostate cancer and chronic fatigue syndrome.<\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

\n<\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a>\n<\/div>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

A WSJ article Monday reported that a federally funded working group is trying to determine whether a virus known as XMRV poses a risk to the nation\u0092s blood supply. So how worried are public-health experts about XMRV? In August, the last time emerging threats were assessed and ranked by the AABB, XMRV hadn\u0092t yet appeared […]<\/p>\n","protected":false},"author":6254,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-519909","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/519909","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/6254"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=519909"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/519909\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=519909"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=519909"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=519909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}